Targeted delivery of therapeutic oligonucleotides in pancreatic cancer
- 12 July 2022
- journal article
- Published by Peertechz Publications Private Limited in Journal of Biology and Medicine
- Vol. 6 (1), 001-004
- https://doi.org/10.17352/jbm.000028
Abstract
Currently, the most common treatment options for pancreatic cancer include chemotherapy, radiation, and surgery. These treatment options are not specific to the cause of the disease and therefore result in a large number of side effects including nausea, fatigue, hair loss, etc. The use of oligonucleotides may be a more efficient and safe method of cancer therapy. This mini-review will cover how oligonucleotides have been used to treat diseases in the past as well as different methods for delivery into the body and finally the applications of oligonucleotides in pancreatic cancer therapy.Keywords
This publication has 22 references indexed in Scilit:
- Non-viral vectors for gene-based therapyNature Reviews Genetics, 2014
- Targeted delivery of antisense oligonucleotides to hepatocytes using triantennary N-acetyl galactosamine improves potency 10-fold in miceNucleic Acids Research, 2014
- Pharmacology of a Central Nervous System Delivered 2′-O-Methoxyethyl–Modified Survival of Motor Neuron Splicing Oligonucleotide in Mice and Nonhuman PrimatesThe Journal of pharmacology and experimental therapeutics, 2014
- Evading Immune Cell Uptake and Clearance Requires PEG Grafting at Densities Substantially Exceeding the Minimum for Brush ConformationMolecular Pharmaceutics, 2014
- Recent advances in delivery of drug–nucleic acid combinations for cancer treatmentJournal of Controlled Release, 2013
- Challenges and Key Considerations of the Enhanced Permeability and Retention Effect for Nanomedicine Drug Delivery in OncologyCancer Research, 2013
- In Vivo Delivery of RNAi with Lipid-Based NanoparticlesAnnual Review of Biomedical Engineering, 2011
- Shear stress and the endothelial transport barrierCardiovascular Research, 2010
- A Positive Modifier of Spinal Muscular Atrophy in the SMN2 GeneAmerican Journal of Human Genetics, 2009
- Enhancement of SMN2 Exon 7 Inclusion by Antisense Oligonucleotides Targeting the ExonPLoS Biology, 2007